254 related articles for article (PubMed ID: 20600917)
1. Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?
Gassani BC; Rezende RM; Paiva-Lima P; Ferreira-Alves DL; dos Reis WG; Bakhle YS; de Francischi JN
Pharmacol Res; 2010 Nov; 62(5):439-43. PubMed ID: 20600917
[TBL] [Abstract][Full Text] [Related]
2. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.
Francischi JN; Chaves CT; Moura AC; Lima AS; Rocha OA; Ferreira-Alves DL; Bakhle YS
Br J Pharmacol; 2002 Nov; 137(6):837-44. PubMed ID: 12411415
[TBL] [Abstract][Full Text] [Related]
4. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan.
França DS; Ferreira-Alves DL; Duarte ID; Ribeiro MC; Rezende RM; Bakhle YS; Francischi JN
Neuropharmacology; 2006 Jul; 51(1):37-43. PubMed ID: 16620880
[TBL] [Abstract][Full Text] [Related]
5. Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia.
Correa JD; Paiva-Lima P; Rezende RM; Dos Reis WG; Ferreira-Alves DL; Bakhle YS; Francischi JN
Life Sci; 2010 Jun; 86(25-26):951-6. PubMed ID: 20451533
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain.
Rezende RM; França DS; Menezes GB; dos Reis WG; Bakhle YS; Francischi JN
Br J Pharmacol; 2008 Feb; 153(4):760-8. PubMed ID: 18157167
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib induces tolerance in a model of peripheral inflammatory pain in rats.
Rezende RM; Paiva-Lima P; Dos Reis WG; Camêlo VM; Bakhle YS; de Francischi JN
Neuropharmacology; 2010 Nov; 59(6):551-7. PubMed ID: 20691196
[TBL] [Abstract][Full Text] [Related]
8. Mathematical analysis of involvement ratio between central and peripheral COX-2 in rat pain models with two types of COX-2 inhibitors with different distribution, celecoxib and CIAA.
Okumura T; Sakakibara A; Murata Y; Kita Y
Eur J Pharmacol; 2008 Jan; 578(1):97-9. PubMed ID: 17716650
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioid and cannabinoid mechanisms are involved in the analgesic effects of celecoxib in the central nervous system.
Rezende RM; Paiva-Lima P; Dos Reis WG; Camêlo VM; Faraco A; Bakhle YS; Francischi JN
Pharmacology; 2012; 89(3-4):127-36. PubMed ID: 22415159
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats.
Nishiyama T
Acta Anaesthesiol Scand; 2006 Feb; 50(2):228-33. PubMed ID: 16430547
[TBL] [Abstract][Full Text] [Related]
11. Treatment with ketanserin produces opioid-mediated hypoalgesia in the late phase of carrageenan-induced inflammatory hyperalgesia in rats.
Huang J; Cai Q; Chen Y; Hong Y
Brain Res; 2009 Dec; 1303():39-47. PubMed ID: 19782054
[TBL] [Abstract][Full Text] [Related]
12. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing.
Simon AM; O'Connor JP
J Bone Joint Surg Am; 2007 Mar; 89(3):500-11. PubMed ID: 17332098
[TBL] [Abstract][Full Text] [Related]
13. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
Lee IO; Seo Y
Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448
[TBL] [Abstract][Full Text] [Related]
14. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
[TBL] [Abstract][Full Text] [Related]
15. The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats.
Khayyal MT; El-Ghazaly MA; El-Hazek RM; Nada AS
Inflammopharmacology; 2009 Oct; 17(5):255-66. PubMed ID: 19798548
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of carrageenan induced heat muscle hyperalgesia in rats using non-selective, preferential and selective COX-2 inhibitors.
Chopade AR; Sayyad FJ; Naikwade NS
Pharmacol Rep; 2014 Jun; 66(3):353-62. PubMed ID: 24905509
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
[TBL] [Abstract][Full Text] [Related]
18. The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.
Knudsen JF; Carlsson U; Hammarström P; Sokol GH; Cantilena LR
Inflammation; 2004 Oct; 28(5):285-90. PubMed ID: 16134002
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antinociceptive efficacy and gastroprotection between celecoxib and diclofenac plus misoprostol in rats.
Reyes-García G; Déciga-Campos M; Medina-Santillan R; Granados-Soto V
Proc West Pharmacol Soc; 2007; 50():69-71. PubMed ID: 18605234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
